Myfortic

In the US, Myfortic (mycophenolic acid systemic) is a member of the drug class selective immunosuppressants and is used to treat Dermatomyositis and Rejection Prophylaxis.

US matches:

• Myfortic


• Myfortic Delayed-Release Tablets

UK matches:

• MYFORTIC film coated gastro-resistant tablets
• MYFORTIC gastro-resistant tablets (SPC)

Ingredient matches for Myfortic

Mycophenolic Acid

Mycophenolic Acid is reported as an ingredient of Myfortic in the following countries:

• South Africa

Mycophenolic Acid sodium (a derivative of Mycophenolic Acid) is reported as an ingredient of Myfortic in the following countries:

• Australia


• Austria


• Belgium


• Brazil


• Canada


• Chile


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Ecuador


• Estonia


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Latvia


• Lithuania


• Luxembourg


• Malaysia


• Malta


• Mexico


• Netherlands


• Norway


• Oman


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Turkey


• United Kingdom


• United States


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.